Question 1

What is NEPAFENAC used for?

Accepted Answer

NEPAFENAC (brand name ILEVRO) is a Other indicated for 1 INDICATIONS AND USAGE ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 )..

Question 2

How does NEPAFENAC work?

Accepted Answer

NEPAFENAC works through the following mechanism: 12.1 Mechanism of Action After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a NSAID. Nepafenac and amfenac are thought to inhibit the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production..

Question 3

What are the most common side effects of NEPAFENAC?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for NEPAFENAC. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is NEPAFENAC the same as ILEVRO?

Accepted Answer

ILEVRO is a brand name for NEPAFENAC. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

NEPAFENAC

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations